Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts

Eleonora Timperi1, Emanuela Romano1,2

  • 1Department of Immunology, INSERM U932, Université Paris Sciences et Lettres (PSL) Research University, Institut Curie, Paris, France.

PubMed

Insights

Tumor-associated macrophages (TAMs) and cancer-associated fibroblasts (CAFs) are key in solid cancers. Single-cell RNA sequencing reveals their complex interactions within the tumor microenvironment, impacting patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Tumor-associated macrophages (TAMs) are abundant in solid cancers and linked to poor prognosis.
  • Cancer-associated fibroblasts (CAFs) influence TAM recruitment, survival, and function.
  • Understanding TAM-CAF interactions is crucial for cancer therapy.

Purpose of the Study:

  • To review recent advances in single-cell RNA sequencing (sc-RNA seq) for studying TAMs and CAFs.
  • To elucidate the phenotypical and functional characteristics of TAMs and CAFs.
  • To highlight the crosstalk between TAMs and CAFs in the tumor microenvironment (TME).

Main Methods:

  • Review of recent literature on sc-RNA seq applications in cancer research.
  • Analysis of studies focusing on TAM and CAF identity and function.
  • Synthesis of findings on TAM-CAF interactions within the TME.

Main Results:

  • sc-RNA seq provides high-resolution data on TAM and CAF heterogeneity.
  • Distinct TAM and CAF subpopulations exhibit specialized roles in cancer progression.
  • Complex crosstalk signaling pathways mediate TAM-CAF interactions.

Conclusions:

  • sc-RNA seq is a powerful tool for dissecting cellular crosstalk in the TME.
  • Targeting TAM-CAF interactions may offer novel therapeutic strategies for solid cancers.
  • Further research is needed to fully understand and exploit these interactions.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K